No Data
No Data
Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
Express News | Myriad Genetics To Present At AACR Annual Meeting On Apr. 28
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
Insiders At Myriad Genetics Sold US$6.5m In Stock, Alluding To Potential Weakness
Leerink Partners Maintains Myriad Genetics(MYGN.US) With Hold Rating
Myriad Genetics Releases Study Results That Shows Patients With Depression Had Fewer Psychiatric Hospitalizations After GeneSight Testing